HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimens
Maja Kiselinova(Ghent University Hospital), Linos Vandekerckhove(Ghent University Hospital), Wim Trypsteen(Ghent University Hospital), Eva Malatinková(Ghent University Hospital), Steven Callens(Ghent University Hospital), Chris Verhofstede(Ghent University), Pawel Bonczkowski(Ghent University Hospital), Anna María Geretti(National Health Service), Karen Vervisch(Ghent University Hospital), Apostolos Beloukas(University of Liverpool), Peter Messiaen(Ghent University Hospital), Ward De Spiegelaere(Ghent University)
Cited by 23
Related Papers
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020
|Clinical Chemistry|2020|501
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
|Nature Medicine|2021|367
Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study
|Clinical Infectious Diseases|2020|295
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
|PLoS Pathogens|2020|231